810 PERCUTANEOUS LASER ABLATION FOR HEARLY-STAGE HEPATOCELLULARCARCINOMA IN SO-CALLED HIGH- RISK LOCATIONS: A RETROSPECTIVE COMPARISON WITH NO HIGH-RISK LOCATIONS LESIONS FOR SAFETY, EFFECTIVENESS AND LONG-TERM OUTCOME

2009 ◽  
Vol 50 ◽  
pp. S296
Author(s):  
A. Petrolati ◽  
Z. Rossi ◽  
C.M. Pacella
Keyword(s):  
Laser Ablation ◽  
High Risk ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Retrospective Comparison ◽  
Safety Effectiveness ◽  
Percutaneous Laser Ablation

Long-term outcome for very high-risk prostate cancer treated primarily with a triple modality approach to include permanent interstitial brachytherapy

Brachytherapy ◽  
2012 ◽  
Vol 11 (4) ◽  
pp. 250-255 ◽  
Author(s):  
Nathan Bittner ◽  
Gregory S. Merrick ◽  
Wayne M. Butler ◽  
Robert W. Galbreath ◽  
Jonathan Lief ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
High Risk ◽  
Interstitial Brachytherapy ◽  
Term Outcome ◽  
Long Term Outcome ◽  
High Risk Prostate Cancer ◽  
Risk Prostate Cancer ◽  
Modality Approach ◽  
Very High

scholarly journals The long-term outcome of treated high-risk nonmuscle-invasive bladder cancer

Cancer ◽  
2012 ◽  
Vol 118 (22) ◽  
pp. 5525-5534 ◽  
Author(s):  
Francis Thomas ◽  
Derek J. Rosario ◽  
Naomi Rubin ◽  
John R. Goepel ◽  
Maysam F. Abbod ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
High Risk ◽  
Invasive Bladder Cancer ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Nonmuscle Invasive Bladder Cancer

scholarly journals Long term outcome of high-risk neuroblastoma patients after immunotherapy with antibody ch14.18 or oral metronomic chemotherapy

BMC Cancer ◽  
2011 ◽  
Vol 11 (1) ◽  
Author(s):  
Thorsten Simon ◽  
Barbara Hero ◽  
Andreas Faldum ◽  
Rupert Handgretinger ◽  
Martin Schrappe ◽  
...  
Keyword(s):  
High Risk ◽  
Metronomic Chemotherapy ◽  
Term Outcome ◽  
Long Term Outcome
Sign in / Sign up

Export Citation Format

Share Document